Paratek Pharmaceuticals, Inc. announced the appointment of Timothy Franson, M.D. as a new, independent director to its board of directors. This appointment, effective as of July 21, brings Paratek's total number of directors to seven, five of whom are independent. He currently serves as Chief Medical Officer for YourEncore.

Dr. Franson has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development (small and large molecule) relating to interactions with the Food and Drug Administration for policy and product issues, as well as interactions with global regulators.